In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 35099996.
- Also identified by DOI 10.7326/J21-0021.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ortega-Paz L, Galli M, Capodanno D, et al. <b>Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.</b> Eur Heart J Cardiovasc Pharmacother. 2021. [Epub ahead of print.] 34519777.
Medical subject headings
- COVID-19